Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q1 FY25 results · Apr–Jun 2024
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹931.75 crore (up 9.3% from Q1 FY24) and net profit of ₹81.06 crore (down 46.4% from Q1 FY24) for Q1 FY25 (Apr–Jun 2024), on a standalone basis.
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 931.75 | 852.53 | +9.3% | 1,002.17 | −7.0% |
| Other income | 7.31 | 10.10 | −27.6% | 13.59 | −46.2% |
| Total income | 939.06 | 862.63 | +8.9% | 1,015.76 | −7.6% |
| Profit before tax | 112.28 | 206.58 | −45.6% | 233.94 | −52.0% |
| Net profit for the period | 81.06 | 151.24 | −46.4% | 154.37 | −47.5% |
| EPS, basic (₹) | 24.97 | 46.59 | −46.4% | 47.56 | −47.5% |
| Net margin (%) | 8.7 | 17.7 | 15.4 |
Standalone
- Filed with BSE
- 29 Aug 2024, 17:59 IST
- Board meeting
- 28 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Audited
- Source
- XBRL filing on BSE